Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Ebiomedicine|April 9, 2020
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancerManish Kohli, Winston Tan, Tiantian Zheng, et al.
European Urology Focus|December 19, 2025
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and ChallengesNeal D Shore, Stephen J Freedland, Lisa G Horvath, et al.
The Prostate|November 15, 2017
Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancerAnton M F Kalsbeek, Eva K F Chan, Judith Grogan, et al.
Aging|October 6, 2016
Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancerAnton M F Kalsbeek, Eva F K Chan, Judith Grogan, et al.
Cancer Research|September 24, 2009
Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profilingLiangli Zhao, Brian Y Lee, David A Brown, et al.
Molecular & Cellular Proteomics : MCP|June 5, 2016
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine ProfilingEmily S Humphrey, Shih-Ping Su, Adnan M Nagrial, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Cancer Research Communications|March 6, 2026
A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation resultsBarak Talmor, Stefano Marastoni, Brandon Lau, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2015
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinomaWendy A Cooper, Thang Tran, Ricardo E Vilain, et al.
Scientific Reports|May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancerHui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Pageof 13